Batchelor T - Search Results

1

MRI Based Bayesian Personalization of a Tumor Growth Model.

Le M, Delingette H, Kalpathy-Cramer J, Gerstner ER, Batchelor T, Unkelbach J, Ayache N. Le M, et al. Among authors: batchelor t. IEEE Trans Med Imaging. 2016 Oct;35(10):2329-2339. doi: 10.1109/TMI.2016.2561098. Epub 2016 Apr 29. IEEE Trans Med Imaging. 2016. PMID: 27164582

2

Primary CNS lymphoma.

Gerstner E, Batchelor T. Gerstner E, et al. Among authors: batchelor t. Expert Rev Anticancer Ther. 2007 May;7(5):689-700. doi: 10.1586/14737140.7.5.689. Expert Rev Anticancer Ther. 2007. PMID: 17492932 Review.

3

Antiangiogenic agents for the treatment of glioblastoma.

Gerstner ER, Duda DG, di Tomaso E, Sorensen G, Jain RK, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Expert Opin Investig Drugs. 2007 Dec;16(12):1895-908. doi: 10.1517/13543784.16.12.1895. Expert Opin Investig Drugs. 2007. PMID: 18041999 Review.

4

Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation.

Gerstner ER, Carson KA, Grossman SA, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Neurology. 2008 Jan 29;70(5):401-2. doi: 10.1212/01.wnl.0000300671.37279.0e. Neurology. 2008. PMID: 18227422 Free PMC article. Clinical Trial. No abstract available.

5

Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas.

Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Curr Opin Neurol. 2008 Dec;21(6):728-35. doi: 10.1097/WCO.0b013e328318402a. Curr Opin Neurol. 2008. PMID: 18989120 Review.

6

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Nat Rev Clin Oncol. 2009 Apr;6(4):229-36. doi: 10.1038/nrclinonc.2009.14. Nat Rev Clin Oncol. 2009. PMID: 19333229 Free PMC article. Review.

7

Anti-vascular endothelial growth factor therapy for malignant glioma.

Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Curr Neurol Neurosci Rep. 2009 May;9(3):254-62. doi: 10.1007/s11910-009-0037-2. Curr Neurol Neurosci Rep. 2009. PMID: 19348715 Free PMC article. Review.

8

Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab.

Gerstner ER, Frosch MP, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. J Clin Oncol. 2010 Feb 20;28(6):e91-3. doi: 10.1200/JCO.2009.25.0233. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933906 No abstract available.

9

Primary central nervous system lymphoma.

Gerstner ER, Batchelor TT. Gerstner ER, et al. Among authors: batchelor tt. Arch Neurol. 2010 Mar;67(3):291-7. doi: 10.1001/archneurol.2010.3. Arch Neurol. 2010. PMID: 20212226 Review.

10

Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.

Gerstner ER, Chen PJ, Wen PY, Jain RK, Batchelor TT, Sorensen G. Gerstner ER, et al. Among authors: batchelor tt. Neuro Oncol. 2010 May;12(5):466-72. doi: 10.1093/neuonc/nop051. Epub 2010 Jan 22. Neuro Oncol. 2010. PMID: 20406897 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters